-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Overweight on Imax, Raises Price Target to $58

Benzinga·10/23/2026 15:45:06
JP Morgan analyst David Karnovsky maintains Imax (NYSE:IMAX) with a Overweight and raises the price target from $50 to $58.